ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 100,77
-1,24%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Fortress Biotech Inc (FBIO)

  7. Fortress Biotech Inc (FBIO) Actualités

FBIO Fortress Biotech Inc

1,75
-0,05 (-2,78%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Fortress Biotech Inc FBIO NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,05 -2,78% 1,75 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,85 1,67 1,86 1,75 1,80
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
02/5/202422:01GLOBEMustang Bio Announces Closing of $4 Million Public Offering
01/5/202422:01GLOBEJourney Medical Corporation Appoints Joseph Benesch as Chief..
30/4/202402:00GLOBEMustang Bio Announces Pricing of $4 Million Public Offering
29/4/202414:00GLOBEAvenue Therapeutics Announces Exercise of Warrants for $4.4..
25/4/202414:30GLOBEJourney Medical Corporation to Present at the Planet..
24/4/202413:30GLOBEAvenue Therapeutics Announces Reverse Stock Split
28/3/202421:05GLOBEFortress Biotech Reports 2023 Financial Results and Recent..
28/3/202414:00GLOBEMustang Bio Announces Vision for CAR T-Cell Therapy Platform..
25/3/202413:30GLOBEAvenue Therapeutics to Host Virtual Key Opinion Leader (KOL)..
21/3/202421:01GLOBEJourney Medical Corporation Reports Full-Year 2023 Financial..
18/3/202421:05GLOBEAvenue Therapeutics Reports Full Year 2023 Financial Results..
18/3/202413:30GLOBEJourney Medical Corporation Announces U.S. FDA Acceptance of..
15/3/202413:30GLOBEJourney Medical Corporation to Announce Year End 2023..
15/3/202413:15GLOBEAvenue Therapeutics Receives Positive Listing Determination..
13/3/202413:30GLOBEJourney Medical Corporation to Participate in the 36th..
12/3/202413:30GLOBEFortress Biotech to Participate in 36th Annual ROTH..
11/3/202413:30GLOBEJourney Medical Corporation Announces Presentation of Data..
11/3/202413:00GLOBEAvenue Therapeutics to Present BAER-101 Preclinical Data at..
07/3/202413:30GLOBEMustang Bio Announces Publication in Nature Medicine of Data..
04/3/202414:30GLOBEFortress Biotech and Cyprium Therapeutics Announce $4.1..
22/2/202414:30GLOBEAvenue Therapeutics Announces Publication in Drug..
11/1/202414:30GLOBEMustang Bio to Participate in the B. Riley Securities 4th..
11/1/202414:00GLOBEAvenue Therapeutics to Present at Sidoti January Micro-Cap..
05/1/202415:15GLOBEAvenue Therapeutics Enters into Warrant Exercise..
05/1/202414:30GLOBEJourney Medical Corporation Submits New Drug Application to..
04/1/202414:30GLOBEAvenue Therapeutics Reaches Final Agreement with the U.S...
03/1/202422:01GLOBEFortress Biotech Announces Closing of $11 Million Registered..
02/1/202422:05GLOBEJourney Medical Corporation Secures Credit Facility with SWK..
02/1/202414:30GLOBEAvenue Therapeutics Announces Completion of Enrollment in..
29/12/202314:20GLOBEFortress Biotech Announces Pricing of $11 Million Registered..
11/12/202314:30GLOBEMustang Bio Presents Updated Phase 1/2 Multicenter Clinical..
06/12/202314:30GLOBECyprium Therapeutics, a Fortress Biotech Subsidiary Company,..
06/12/202314:30PRNUSSentynl Therapeutics Completes Asset Transfer of CUTX-101..
06/12/202314:00GLOBEJourney Medical Corporation Announces Successful Completion..
01/12/202314:30GLOBEAvenue Therapeutics to Present at American Epilepsy Society..
14/11/202322:10GLOBEFortress Biotech Reports Third Quarter 2023 Financial..
14/11/202322:05GLOBEMustang Bio Reports Third Quarter 2023 Financial Results and..
14/11/202322:01GLOBEFortress Biotech Announces Closing of $10.0 Million Public..
13/11/202322:05GLOBEAvenue Therapeutics Reports Third Quarter 2023 Financial..
10/11/202314:15GLOBEFortress Biotech Announces Pricing of $10.0 Million Public..
09/11/202323:05GLOBEFortress Biotech Announces Launch of Proposed Public..
07/11/202322:01GLOBEJourney Medical Corporation Reports Third Quarter 2023..
02/11/202320:00GLOBEAvenue Therapeutics Announces Closing of $5.0 Million Public..
02/11/202314:28GLOBEMustang Bio Announces MB-106 CD20-Targeted CAR-T Data..
31/10/202314:15GLOBEAvenue Therapeutics Announces Pricing of $5.0 Million Public..
31/10/202313:30GLOBEJourney Medical Corporation to Announce Third Quarter 2023..
30/10/202319:15GLOBEMustang Bio Announces Closing of $4.4 Million Registered..
26/10/202318:30GLOBEMustang Bio Announces $4.4 Million Registered Direct..
26/10/202315:00GLOBEMustang Bio Announces FDA Acceptance of IND Application for..
20/10/202314:30GLOBEJourney Medical Corporation Announces Data from..

Dernières Valeurs Consultées

NASDAQ
FBIO
Fortress Biotech
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés